In this edition of Newsmaker, FOX 10's John Hook first talks with Dr. Swathi Varanasi-Diaz about the impact of weight loss drugs like Wegovy or Ozempic. In the second segment, John chats with Baywatch ...
Despite this escalating demand for popular GLP-1 drugs, the prices for some of these products are actually dropping. Dr.
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according ...
Novo Nordisk is a bargain stock with tremendous growth potential. Vertex Pharmaceuticals has seven clear paths to growth ...
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
The holidays are a time known for feasting on delicious food, but that might not be possible for people taking weight-loss drugs.
Novo Nordisk, the manufacturer of Ozempic and Wegovy, has petitioned the Food and Drug Administration (FDA) to add ...
It appears not all weight-loss drugs are created equal. The users of one drug report more weight loss comparted to another ...
Data suggests that dramatic weight loss, including via GLP-1 drugs, could save Americans big bucks in healthcare spending.
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Ozempic and other GLP-1 drugs have surged in popularity, dominating U.S. medication spending in 2023 for their effectiveness in managing diabetes and promoting weight loss. As demand grows, promising ...
The weight loss revolution is in full swing, with the number of patients receiving Wegovy (NVO) having doubled while those ...